C07C 279/24
Y being a hetero atom
C07C279/24 (Y being a hetero atom) appears on 258 US grants and 219 published applications in this corpus.
Search patents in C07C- Granted patents
- 258
- Published applications
- 219
- Assignees
- 189
- Inventors
- 700
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 7 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 9 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 11 | 0 |
| 1999 | 5 | 0 |
| 2000 | 10 | 0 |
| 2001 | 4 | 1 |
| 2002 | 4 | 1 |
| 2003 | 5 | 6 |
| 2004 | 4 | 5 |
| 2005 | 4 | 2 |
| 2006 | 2 | 2 |
| 2007 | 4 | 7 |
| 2008 | 1 | 7 |
| 2009 | 1 | 6 |
| 2010 | 2 | 5 |
| 2011 | 5 | 8 |
| 2012 | 4 | 17 |
| 2013 | 3 | 6 |
| 2014 | 5 | 10 |
| 2015 | 12 | 12 |
| 2016 | 7 | 12 |
| 2017 | 10 | 19 |
| 2018 | 16 | 11 |
| 2019 | 15 | 16 |
| 2020 | 10 | 16 |
| 2021 | 7 | 10 |
| 2022 | 12 | 20 |
| 2023 | 5 | 6 |
| 2024 | 9 | 5 |
| 2025 | 5 | 4 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Alpha-carbonyl alkenyl ester preparation method therefor and application thereof15 Sep 2026US 12,735,449 B2Jiangxi Normal University
- Bis-biguanide compounds, pharmaceutical compositions and uses in managing cancer24 Mar 2026US 12,582,618 B2Emory University
- Nanoparticle composition and method of inhibiting ovarian cancer cell viability6 Jan 2026US 12,515,963 B2
- Compounds with biguanidyl radical and uses thereof16 Sep 2025US 12,415,781 B2Centre National De La Recherche Scientifique
- Compounds and compositions for intracellular delivery of therapeutic agents2 Sep 2025US 12,404,232 B2ModernaTX, Inc.
- Improved enzyme-assisted synthesis of chlorhexidine base30 Jul 2026US 2026/0218252 A1Xttrium Laboratories, Inc.
- Bis-Biguanide Compounds, Pharmaceutical Compositions and Uses in Managing Cancer2 Jul 2026US 2026/0183251 A1Emory University
- Nanoparticle composition and method of use and manufacture19 Mar 2026US 2026/0078012 A1
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
- Compounds with biguanidyl radical and uses thereof8 Jan 2026US 2026/0008748 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- 1,2-Biguanides80US 3,960,949 ASchering Corporation · 1976
- Meta-substituted phenylene derivatives72US 5,773,646 AG. D. Searle & Co. · 1998
- Antibacterially active hexamethylene-bis-biguanides70US 4,022,834 AA/S Farmaceutisk Industri · 1977
- Cationic lipids69US 5,777,153 AGilead Sciences, Inc. · 1998